Peter Jandus
Overview
Explore the profile of Peter Jandus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
186
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perez-Codesido S, Jandus P, Seebach J, Harr T
Rev Med Suisse
. 2025 Jan;
21(900-1):9-12.
PMID: 39812277
In recent years, studies have focused on the in vitro diagnosis of immediate drug reactions, with new recommendations concerning the use of the basophil activation test. Air pollution, particularly fine...
2.
Stolz D, Schuoler C, Charbonnier F, Bridevaux P, Jandus P, Leuppi J, et al.
J Asthma Allergy
. 2024 Dec;
17:1301-1312.
PMID: 39734474
Purpose: Although studies have evaluated benralizumab, a monoclonal IL-5 receptor α antibody in severe eosinophilic asthma (SEA), in real-world settings, additional evidence is needed to further characterize its effectiveness in...
3.
Jandus C, Jandus P
Int Arch Allergy Immunol
. 2024 Jun;
185(10):975-996.
PMID: 38852585
Background: Intravenous immunoglobulin (IVIg) has been used for almost 40 years in the treatment of autoimmune and systemic inflammatory diseases. Numerous cells are involved in the innate immune response, including...
4.
Lanzlinger Y, Leroquais C, Meynard A, Jandus P, Harr T, Chevallier-Lugon C
Rev Med Suisse
. 2023 Sep;
19(843):1739-1742.
PMID: 37753911
In Switzerland, almost 20 % of the population suffers from allergic rhinitis, which has a major impact on patients' quality of life. Allergen avoidance remains the most effective measure but...
5.
Sultan J, Goethals M, Jandus P, Harr T, Perone N, Braillard O
Rev Med Suisse
. 2023 Sep;
19(843):1730-1733.
PMID: 37753909
Urticaria is a frequent disease and exist in an acute or chronic form. The pathophysiology, focused on mast cells and histamine among other mediators, is an active research field but...
6.
Fasshauer M, Borte M, Bitzenhofer M, Pausch C, Pittrow D, Park M, et al.
Adv Ther
. 2023 Sep;
40(12):5168-5187.
PMID: 37751025
Introduction: The CORE study aimed to provide a detailed understanding of real-world immune globulin subcutaneous (human) 20% solution (Ig20Gly) utilization in patients with primary immunodeficiency diseases (PIDs) in Germany and...
7.
Matthes T, Jandus P
Rev Med Suisse
. 2023 Apr;
19(821):668-673.
PMID: 37017348
Infections are among the leading causes of morbidity and mortality in lymphoproliferative malignancies such as multiple myeloma (MM) and chronic lymphocytic leukemia (CLL). The causes of infections are often multifactorial...
8.
Jandus P, Bitzenhofer-Gruber M
Ther Umsch
. 2022 Jul;
79(6):279-283.
PMID: 35903831
Antibodydeficiencies Epidemiology, Clinical manifestation, Diagnostics and Therapy Primary Immune Deficiencies (PID) are caused by a genetically induced malformation/dysfunction of the immune system. Leading symptoms include susceptibility to infection, autoimmune diseases,...
9.
10.
Blanchard Rohner G, Jandus P
Ther Umsch
. 2022 Jul;
79(6):307-311.
PMID: 35903827
Vaccination and Vaccination Response in Immunodeficiency Vaccination of patients with immunodeficiencies is challenging. A lack of increase in vaccine antibody titers or vaccine-induced infections may indicate primary immunodeficiency. All vaccines...